MedPath

UNIVERSITY OF ARIZONA

UNIVERSITY OF ARIZONA logo
🇺🇸United States
Ownership
Private
Established
1885-01-01
Employees
10K
Market Cap
-
Website
http://www.arizona.edu

Clinical Trials

433

Active:20
Completed:217

Trial Phases

6 Phases

Early Phase 1:16
Phase 1:30
Phase 2:66
+3 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (375 trials with phase data)• Click on a phase to view related trials

Not Applicable
232 (61.9%)
Phase 2
66 (17.6%)
Phase 1
30 (8.0%)
Phase 4
20 (5.3%)
Early Phase 1
16 (4.3%)
Phase 3
11 (2.9%)

Project REST: Club Sports

Not Applicable
Withdrawn
Conditions
Poor Quality Sleep
First Posted Date
2025-08-05
Last Posted Date
2025-08-11
Lead Sponsor
University of Arizona
Registration Number
NCT07103759
Locations
🇺🇸

University of Arizona, Tucson, Arizona, United States

Efficacy of Non-weight Based, Low Dose Dex-Dex Adjuncts in Prolonging Peripheral Nerve Blocks

Not Applicable
Active, not recruiting
Conditions
Postoperative Pain
Nausea and Vomiting, Postoperative
Dizziness
Constipation
Duration of Response
Narcotics Consumption
Pain After Surgery
Interventions
Drug: Ropivacaine with low, non weight based Dexamethasone additive
Drug: Low, non-weight based dose of Dexamethasone and Dexmedetomidine in peripheral nerve blocks
First Posted Date
2025-08-01
Last Posted Date
2025-08-13
Lead Sponsor
University of Arizona
Target Recruit Count
100
Registration Number
NCT07099222
Locations
🇺🇸

Banner - University Medical Center South, Tucson, Arizona, United States

Omega-3D: Omega-3 for Diet-Driven Health Disparities

Not Applicable
Not yet recruiting
Conditions
Heart Health Markers
Cardiovascular Diseases
Omega 3 Fatty Acids
First Posted Date
2025-07-22
Last Posted Date
2025-07-24
Lead Sponsor
University of Arizona
Target Recruit Count
200
Registration Number
NCT07078344
Locations
🇺🇸

School of Nutritional Sciences and Wellness, Tucson, Arizona, United States

🇺🇸

Georgetown University, Washington, District of Columbia, United States

Antibiotic Impregnated Beads in Osteomyelitis

Not Applicable
Not yet recruiting
Conditions
Osteomyelitis of the Foot
Antibiotic Impregnated Beads
Osteomyelitis of Lower Extremities
Interventions
Device: Calcium sulfate beads (sham beads)
Drug: Antibiotic loaded calcium sulfate beads
First Posted Date
2025-07-18
Last Posted Date
2025-07-18
Lead Sponsor
University of Arizona
Target Recruit Count
100
Registration Number
NCT07072923

The Clinical Application of Apple AirPods Pro 2 vs. Hearing Aids

Not Applicable
Not yet recruiting
Conditions
Hearing Loss
First Posted Date
2025-07-01
Last Posted Date
2025-07-10
Lead Sponsor
University of Arizona
Target Recruit Count
30
Registration Number
NCT07044518
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 87
  • Next

News

Octapharma's PANZYGA Shows Mixed Results in Phase 3 PANS Trial, Achieves Significant Secondary Endpoint

Octapharma's phase 3 trial of PANZYGA for pediatric acute-onset neuropsychiatric syndrome (PANS) missed its primary endpoint of reducing obsessive-compulsive symptoms measured by CY-BOCS score.

Ketamine Shows Promise in Restoring Motor Control in Parkinson's Patients with Dyskinesia

Researchers have discovered that levodopa-induced dyskinesia in Parkinson's patients involves a functional disconnection of the motor cortex from movement control.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.